This was the stock's fourth consecutive day of losses.

Boston Scientific (NYSE: BSX) announced the completion of the first-ever cases with its Faraflex mapping and pulsed field ...

TUESDAY, Feb. 25, 2025 (HealthDay News) -- Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S. Food and Drug Administration.

Bearish flow noted in Boston Scientific (BSX) with 5,153 puts trading, or 4x expected. Most active are Mar-25 100 puts and Mar-25 103 calls, ...

Boston Scientific announced that its Europe-based subsidiary priced a public offering totaling $1.57 billion (€1.5 billion).

Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing strong growth momentum ...

The FDA is further elevating a pacemaker recall from Boston Scientific that it first broadcast in December over certain ...

Boston Scientific has recalled its Accolade pacemaker devices due to a manufacturing issue that could cause the devices to enter safety mode, requiring replacement.

At the town hall of the annual gathering of the American Association for the Advancement of Science, Trump’s name was largely ...

The action, tied to two deaths, is among the latest in a surge of recalls by the agency, with nearly 100 Class I recalls in ...

The tools ideate on Boston Scientific’s Farapulse PFA system, which contributed towards a 172% uptick in the company’s Q4 ...